Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05764174 · ClinicalTrials.gov registry record · NA
Digital Applications to Monitor Novel Coronavirus Disease and Response in Colombia - Syndromic and Vaccination Surveillance
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 2,409
- Enrollment target
NCT05764174 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 2,409 participants.
The verdict
NCT05764174, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,409 participants
- Enrollment target
Study Summary
Brief Summary: The main objective of this activity is to assess the effectiveness of different messaging strategies (factual, narrative, mixed and a control) to promote COVID-19 adult vaccination.
Interventions
- BEHAVIORAL Factual messages
- BEHAVIORAL Narrative message
- BEHAVIORAL Mixed message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,409 participants |
| Start Date | 2022-09-21 |
| Est. Completion | 2022-12-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05764174
The ClinicalTrials.gov registry entry for NCT05764174 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,409 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Factual messages is the first listed.
NCT05764174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05764174 about?
NCT05764174 is a clinical study titled "Digital Applications to Monitor Novel Coronavirus Disease and Response in Colombia - Syndromic and Vaccination Surveillance". Brief Summary: The main objective of this activity is to assess the effectiveness of different messaging strategies (factual, narrative, mixed and a control) to promote COVID-19 adult vaccination.
What is the current status of trial NCT05764174?
This trial is currently completed. It is a NA study. The enrollment target is 2,409 participants. The study started on 2022-09-21. Estimated completion is 2022-12-17.
What interventions are being tested in trial NCT05764174?
The interventions under investigation include: Factual messages (BEHAVIORAL), Narrative message (BEHAVIORAL), Mixed message (BEHAVIORAL).
Who is sponsoring clinical trial NCT05764174?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.